Magnetic resonance imaging of uterine malignancies

Topics in Magnetic Resonance Imaging

Volumn 17, Issue 6, 2006, Pages 365-377

  Whitten, Camilla R ^a   DeSouza, Nandita M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Cervical cancer; Endometrial cancer; MRI; Uterine sarcomas; Uterus

Indexed keywords

CANCER LOCALIZATION; CANCER SURVIVAL; CONTRAST ENHANCEMENT; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM SARCOMA; FEMALE FERTILITY; FIBROSARCOMA; HUMAN; LEIOMYOSARCOMA; LYMPHADENECTOMY; LYMPHOMA; MIXED MULLERIAN TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTMENOPAUSE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RECURRENT DISEASE; REVIEW; RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY; SMALL CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX CANCER; VAGINAL HYSTERECTOMY;

FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; PHYSICIAN'S PRACTICE PATTERNS; UTERINE NEOPLASMS; UTERUS;

EID: 34248184051     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b013e3180417d47     Document Type: Review

References (97)

1. Daniels RV, McCuskey C. Abnormal vaginal bleeding in the nonpregnant patient. Emerg Med Clin North Am. 2003;21:751-772.
2. Moodley M, Roberts C. Clinical pathway for the evaluation of postmenopausal bleeding with an emphasis on endometrial cancer detection. J Obstet Gynaecol. 2004;24:736-741.
3. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364:249-256.
4. Marti-Bonmati L, Graells M, Ronchera-Oms CL. Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs. Abdom Imaging. 1996;21:309-313.
5. Dosda R, Marti-Bonmati L, Ronchera-Oms CL, et al. Effect of subcutaneous butylscopolamine administration in the reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations. Eur Radiol. 2003;13:294-298.
6. deSouza NM, Dina R, McIndoe GA, et al. Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension. Gynecol Oncol. 2006;102:80-85.
7. deSouza NM, McIndoe GA, Soutter WP, et al. Value of magnetic resonance imaging with an endovaginal receiver coil in the pre-operative assessment of stage I and IIa cervical neoplasia. Br J Obstet Gynaecol. 1998;105:500-507.
8. Hricak H, Hamm B, Semelka RC, et al. Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging. Radiology. 1991;181:95-106.
9. Postema S, Pattynama PM, Broker S, et al. Fast dynamic contrast-enhanced colour-coded MRI in uterine cervix carcinoma: useful for tumour staging? Clin Radiol. 1998;53:729-734.
10. Bartoli JM, Moulin G, Delannoy L, et al. The normal uterus on magnetic resonance imaging and variations associated with the hormonal state. Surg Radiol Anat. 1991;13:213-220.
11. deSouza NM, Hawley IC, Schwieso JE, et al. The uterine cervix on in vitro and in vivo MR images: a study of zonal anatomy and vascularity using an enveloping cervical coil. AJR Am J Roentgenol. 1994;163:607-612.
12. Yamashita Y, Takahashi M, Sawada T, et al. Carcinoma of the cervix: dynamic MR imaging. Radiology. 1992;182:643-648.
13. Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding - a Nordic multicenter study. Am J Obstet Gynecol. 1995;172:1488-1494.
14. Kim SH, Kim HD, Song YS, et al. Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr. 1995;19:766-772.
15. Roy C, Le Bras Y, Mangold L, et al. Small pelvic lymph node metastases: evaluation with MR imaging. Clin Radiol. 1997;52:437-440.
16. Kim JY, Harisinghani MG. MR imaging staging of pelvic lymph nodes. Magn Reson Imaging Clin N Am. 2004;12:581-586.
17. Ceccaroni M, Savelli L, Bovicelli A. Prognostic value of pelvic lymphadenectomy in surgical treatment of apparent stage I endometrial cancer. Anticancer Res. 2004;24:2073-2078.
18. Zuurendonk LD, Smit RA, Mol BW, et al. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer. Eur J Surg Oncol. 2006;32:450-454.
19. Kitchener HC, Blake P. ASTEC. A study in the treatment of endometrial cancer. A randomised trial of lymphadenopathy and of adjuvant external beam radiotherapy in the treatment of endometrial cancer. ISRCTN 1657884. MRC, Randomized controlled trials register.
20. Kitchener HC, Redman CW, Swart AMC, et al. ASTEC (surgery component): a study in the treatment of endometrial cancer: a randomised trial of lymphadenectomy in the treatment of endometrial cancer (ISRCTN 16571884). Int J Gynecol Cancer. 2005;15(S2):77. Abstract.
21. Hardesty LA, Sumkin JH, Hakim C, et al. The ability of helical CT to preoperatively stage endometrial carcinoma. AJR Am J Roentgenol. 2001;176:603-606.
22. Sironi S, Taccagni G, Garancini P, et al. Myometrial invasion by endometrial carcinoma: assessment by MR imaging. AJR Am J Roentgenol. 1992;158:565-569.
23. Frei KA, Kinkel K, Bonel HM, et al. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging - a meta-analysis and Bayesian analysis. Radiology. 2000;216:444-449.
24. Sironi S, Colombo E, Villa G, et al. Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology. 1992;185:207-212.
25. Gordon AN, Fleischer AC, Dudley BS, et al. Preoperative assessment of myometrial invasion of endometrial adenocarcinoma by sonography (US) and magnetic resonance imaging (MRI). Gynecol Oncol. 1989;34:175-179.
26. Lien HH, Blomlie V, Trope C, et al. Cancer of the endometrium: value of MR imaging in determining depth of invasion into the myometrium. AJR Am J Roentgenol. 1991;157:1221-1223.
27. Powell MC, Womack C, Buckley J, et al. Pre-operative magnetic resonance imaging of stage 1 endometrial adenocarcinoma. Br J Obstet Gynaecol. 1986;93:353-360.
28. Leminen A, Forss M, Lehtovirta P. Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors. Acta Obstet Gynecol Scand. 1995;74:61-66.
29. Nagar H, Dobbs S, McClelland HR, et al. The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer. Gynecol Oncol. 2006;103:431-434.
30. Rockall AG, Sohaib SA, Harisinghani MG, et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol. 2005;23:2813-2821.
31. Vassallo P, Matei C, Heston WD, et al. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology. 1994;193:501-506.
32. Williams AD, Cousins C, Soutter WP, et al. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. AJR Am J Roentgenol. 2001;177:343-348.
33. Ebner F, Kressel HY, Mintz MC, et al. Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T. Radiology. 1988;166:333-340.
34. Sugimura K, Okizuka H. Postsurgical pelvis: treatment follow-up. Radiol Clin North Am. 2002;40:659-680. viii.
35. Mayr NA, Yuh WT, Zheng J, et al. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys. 1997;39:395-404.
36. Levenback C, Dershaw DD, Rubin SC. Endoluminal ultrasound staging of cervical cancer. Gynecol Oncol. 1992;46:186-190.
37. Subak LL, Hricak H, Powell CB, et al. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol. 1995;86:43-50.
38. Kim SH, Choi BI, Lee HP, et al. Uterine cervical carcinoma: comparison of CT and MR findings. Radiology. 1990;175:45-51.
39. Hricak H, Lacey CG, Sandles LG, et al. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology. 1988;166:623-631.
40. Togashi K, Nishimura K, Sagoh T, et al. Carcinoma of the cervix: staging with MR imaging. Radiology. 1989;171:245-251.
41. Greco A, Mason P, Leung AW, et al. Staging of carcinoma of the uterine cervix: MRI-surgical correlation. Clin Radiol. 1989;40:401-405.
42. Rubens D, Thornbury JR, Angel C, et al. Stage IB cervical carcinoma: comparison of clinical, MR, and pathologic staging. AJR Am J Roentgenol. 1988;150:135-138.
43. Powell MC, Worthington BS, Sokal M, et al. Magnetic resonance imaging - its application to cervical carcinoma. Br J Obstet Gynaecol. 1986;93:1276-1285.
44. Ho CM, Chien TY, Jeng CM, et al. Staging of cervical cancer: comparison between magnetic resonance imaging, computed tomography and pelvic examination under anesthesia. J Formos Med Assoc. 1992;91:982-990.
45. Kim SH, Choi BI, Han JK, et al. Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr. 1993;17:633-640.
46. Burghardt E, Baltzer J, Tulusan AH, et al. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer. 1992;70:648-655.
47. Baltzer J, Koepcke W. Tumor size and lymph node metastases in squamous cell carcinoma of the uterine cervix. Arch Gynecol. 1979;227:271-278.
48. Dargent D, Frobert JL, Beau G. V factor (tumor volume) and T factor (FIGO classification) in the assessment of cervix cancer prognosis: the risk of lymph node spread. Gynecol Oncol. 1985;22:15-22.
49. Pickel H, Haas J, Lahousen M. Prognostic factors in cervical cancer on the basis of morphometric evaluation. Baillieres Clin Obstet Gynaecol. 1988;2:805-815.
50. Zreik TG, Chambers JT, Chambers SK. Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer. Obstet Gynecol. 1996;87:741-746.
51. Sardi J, Sananes C, Giaroli A, et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol. 1993;49:156-165.
52. Hricak H, Quivey JM, Campos Z, et al. Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys. 1993;27:791-801.
53. Mayr NA, Tali ET, Yuh WT, et al. Cervical cancer: application of MR imaging in radiation therapy. Radiology. 1993;189:601-608.
54. Peppercorn PD, Jeyarajah AR, Woolas R, et al. Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experience. Radiology. 1999;212:395-399.
55. Burghardt E, Hofmann HM, Ebner F, et al. Magnetic resonance imaging in cervical cancer: a basis for objective classification. Gynecol Oncol. 1989;33:61-67.
56. deSouza NM, Scoones D, Krausz T, et al. High-resolution MR imaging of stage I cervical neoplasia with a dedicated transvaginal coil: MR features and correlation of imaging and pathologic findings. AJR Am J Roentgenol. 1996;166:553-559.
57. deSouza NM, Soutter WP, McIndoe GA, et al. Stage I cervical cancer: tumor volume by magnetic resonance imaging of screen-detected versus symptomatic lesions. J Natl Cancer Inst. 1997;89:1314-1315.
58. Plante M, Renaud MC, Francois H. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol. 2004;94:614-623.
59. Delikatny EJ, Russell P, Hunter JC, et al. Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. Radiology. 1993;188:791-796.
60. Mahon MM, Williams AD, Soutter WP, et al. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. NMR Biomed. 2004;17:1-9.
61. Kim MJ, Chung JJ, Lee YH, et al. Comparison of the use of the transrectal surface coil and the pelvic phased-array coil in MR imaging for preoperative evaluation of uterine cervical carcinoma. AJR Am J Roentgenol. 1997;168:1215-1221.
62. Doi T, Yamashita Y, Yasunaga T, et al. Adenoma malignum: MR imaging and pathologic study. Radiology. 1997;204:39-42.
63. Hawighorst H, Knapstein PG, Knopp MV, et al. Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. MAGMA. 1999;8:55-62.
64. Postema S, Pattynama PM, van Rijswijk CS, et al. Cervical carcinoma: can dynamic contrast-enhanced MR imaging help predict tumor aggressiveness? Radiology. 1999;210:217-220.
65. Yuhara A, Akamatsu N, Sekiba K. Use of transrectal radial scan ultrasonography in evaluating the extent of uterine cervical cancer. J Clin Ultrasound. 1987;15:507-517.
66. Lam WW, So NM, Yang WT, et al. Detection of parametrial invasion in cervical carcinoma: role of short tau inversion recovery sequence. Clin Radiol. 2000;55:702-707.
67. Goto M, Okamura S, Ueki M, et al. Evaluation of magnetic resonance imaging in the diagnosis of extension in uterine cervical cancer cases with special attention to imaging planes. Nippon Sanka Fujinka Gakkai Zasshi. 1990;42:1627-1633.
68. Wiener JI, Chako AC, Merten CW, et al. Breast and axillary tissue MR imaging: correlation of signal intensities and relaxation times with pathologic findings. Radiology. 1986;160:299-305.
69. Flueckiger F, Ebner F, Poschauko H, et al. Cervical cancer: serial MR imaging before and after primary radiation therapy - a 2-year follow-up study. Radiology. 1992;184:89-93.
70. Naganawa S, Sato C, Kumada H, et al. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol. 2005;15:71-78.
71. Belgrad R, Elbadawi N, Rubin P. Uterine sarcoma. Radiology. 1975;114:181-188.
72. Sahdev A, Sohaib SA, Jacobs I, et al. MR imaging of uterine sarcomas. AJR Am J Roentgenol. 2001;177:1307-1311.
73. McGee J, Isaacson PG, Wright A. Oxford Textbook of Pathology. New York, NY: Oxford University Press; 1992.
74. Acharya S, Hensley ML, Montag AC, et al. Rare uterine cancers. Lancet Oncol. 2005;6:961-971.
75. Kido A, Togashi K, Koyama T, et al. Diffusely enlarged uterus: evaluation with MR imaging. Radiographics. 2003;23:1423-1439.
76. Oliva E, Clement PB, Young RH. Mesenchymal tumours of the uterus; selected topics emphasizing diagnostic pitfalls. Curr Diagn Pathol. 2002;8:268-282.
77. Janus C, White M, Dottino P, et al. Uterine leiomyosarcoma - magnetic resonance imaging. Gynecol Oncol. 1989;32:79-81.
78. Pattani SJ, Kier R, Deal R, et al. MRI of uterine leiomyosarcoma. Magn Reson Imaging. 1995;13:331-333.
79. Shapeero LG, Hricak H. Mixed mullerian sarcoma of the uterus: MR imaging findings. AJR Am J Roentgenol. 1989;153:317-319.
80. Ohguri T, Aoki T, Watanabe H, et al. MRI findings including gadolinium-enhanced dynamic studies of malignant, mixed mesodermal tumors of the uterus: differentiation from endometrial carcinomas. Eur Radiol. 2002;12:2737-2742.
81. Worthington JL, Balfe DM, Lee JK, et al. Uterine neoplasms: MR imaging. Radiology. 1986;159:725-730.
82. Koyama T, Togashi K, Konishi I, et al. MR imaging of endometrial stromal sarcoma: correlation with pathologic findings. AJR Am J Roentgenol. 1999;173:767-772.
83. Ueda M, Otsuka M, Hatakenaka M, et al. MR imaging findings of uterine endometrial stromal sarcoma: differentiation from endometrial carcinoma. Eur Radiol. 2001;11:28-33.
84. Gandolfo N, Gandolfo NG, Serafini G, et al. Endometrial stromal sarcoma of the uterus: MR and US findings. Eur Radiol. 2000;10:776-779.
85. Ueda M, Otsuka M, Hatakenaka M, et al. Uterine endometrial stromal sarcoma located in uterine myometrium: MRI appearance. Eur Radiol. 2000;10:780-782.
86. Toprak U, Pasaoglu E, Karademir MA, et al. Sonographic, CT, and MRI findings of endometrial stromal sarcoma located in the myometrium and associated with peritoneal inclusion cyst. AJR Am J Roentgenol. 2004;182:1531-1533.
87. La Fianza A, Meloni G, Alberici E, et al. Magnetic resonance appearance of endometrial sarcoma: report of a case with unusual findings. Magn Reson Imaging. 1999;17:637-640.
88. Yamada I, Suzuki S. Primary uterine lymphoma: MR imaging. AJR Am J Roentgenol. 1993;160:662-663.
89. Kawakami S, Togashi K, Kojima N, et al. MR appearance of malignant lymphoma of the uterus. J Comput Assist Tomogr. 1995;19:238-242.
90. Suzuki Y, Tamaki Y, Hasegawa M, et al. Magnetic resonance images of primary malignant lymphoma of the uterine body: a case report. Jpn J Clin Oncol. 2000;30:519-521.
91. Kimura I, Togashi K, Tsutsui K, et al. MR imaging of gynecologic lymphoma. J Comput Assist Tomogr. 1991;15:500-501.
92. Kim YS, Koh BH, Cho OK, et al. MR imaging of primary uterine lymphoma. Abdom Imaging. 1997;22:441-444.
93. Yamamoto T, Maeda M, Mori M, et al. MR imaging of small cell carcinoma of the uterus with associated inappropriate secretion of antidiuretic hormone. AJR Am J Roentgenol. 2000;174:1167-1168.
94. Ju W, Park IA, Kim SH, et al. Small cell carcinoma of the uterine corpus manifesting with visual dysfunction. Gynecol Oncol. 2005;99:504-506.
95. Kim SH, Hwang HY, Choi BI. Uterine metastasis from stomach cancer: radiological findings. Clin Radiol. 1990;42:285-286.
96. Coutts MA, Borthwick NJ, Hungerford JL, et al. Post-menopausal bleeding: a rare presentation of metastatic uveal melanoma. Pathol Oncol Res. 2006;12:184-187.
97. Metser U, Haider MA, Khalili K, et al. MR imaging findings and patterns of spread in secondary tumor involvement of the uterine body and cervix. AJR Am J Roentgenol. 2003;180:765-769.